GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF

Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30

$49.51+0.83 (+1.71%)

Close on Oct 30, 2026Market cap $106.83BP/E 13.3Yield –

Earnings

Quarterly results appear here once GSK files an earnings release with the SEC (Form 8-K, Item 2.02, or Form 6-K).

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GSK.

Revenue growth4.1% · median 4.4%

Gross margin72.4% · median 71.1%

Net margin17.5% · median 6.8%

Advertisement
300 × 250